Supplier · public contract awards

AbbVie Deutschland GmbH & Co. KG public contracts.

AbbVie Deutschland GmbH & Co. KG has won 164 public contracts between 2017 and 2026 from 15 public buyers in Germany. Its most frequent buyer is GWQ ServicePlus AG (25 awards). Outside TED, published values total €3.2 million across 6 awards. 90 awards were published on TED; the median contract size is about €210,000 (6 contracts with a value).

164Contracts won
15Public buyers
1Country
Jul 2026Latest award

Latest contracts won

Németország – Gyógyszerészeti termékek – Vereinbarung nach § 130c SGB V für das Arzneimittel Maviret mit der Wirkstoffkombination Glecaprevir/Pibrenta
Awarded by AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · Germany
16 Jul 2026Awarded
Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dexamethason (au
Awarded by DAK-Gesundheit · Germany
16 Jun 2026Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstofffixkombination Glecaprevir und Pibre
Awarded by AOK Baden-Württemberg · Germany
30 Mar 2026Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026
Awarded by Pbmg Eg · Germany
2 Mar 2026Awarded
Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bimatoprost + Ti
Awarded by DAK-Gesundheit · Germany
29 Sep 2025Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025
Awarded by Pbmg Eg · Germany
5 May 2025Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025
Awarded by Pbmg Eg · Germany
15 Apr 2025Awarded
Németország – Gyógyszerészeti termékek – Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V zum Wirkstoff Aquipta (Atogepant)
Awarded by GWQ ServicePlus AG · Germany
31 Mar 2025Awarded
Németország – Gyógyszerészeti termékek – Vertragsabschluss zum Arzneimittelwirkstoff Atogepant, Verkaufsname: Aquipta , Unternehmen: AbbVie Deutschlan
Awarded by AOK Rheinland/Hamburg - Die Gesundheitskasse · Germany
19 Feb 2025Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 SGB V / § 130c Absatz 1 SGB V - Aquipta (Wirkstoff: Ato
Awarded by DAK-Gesundheit · Germany
19 Feb 2025Awarded

Contracts won by year

Contracts won by year

from the published records
20174
20188
20196
20208
20226
20236
202410
20259
20267

Published value, by currency (feeds other than TED)

EUR · 6 valued
€3.2 million

Typical contract size on TED

EUR · median of 6 contracts
€210,000

From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.

Bid with askTender

Bidding against AbbVie Deutschland GmbH & Co. KG?

askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.

Start bidding See open tenders